**Core Concept**
The muscarinic receptors are a subtype of acetylcholine receptors that are involved in various physiological processes, including smooth muscle contraction, glandular secretion, and regulation of the autonomic nervous system. These receptors are specifically activated by acetylcholine, a neurotransmitter released by parasympathetic nerve endings.

**Why the Correct Answer is Right**
The muscarinic receptors are activated by acetylcholine through a mechanism involving the binding of acetylcholine to the receptor's extracellular ligand-binding domain. This binding causes a conformational change in the receptor, leading to the activation of G-proteins and the subsequent stimulation of various downstream signaling pathways. Atropine, a muscarinic receptor antagonist, competes with acetylcholine for binding to the receptor, thereby blocking its activation. This is due to the structural similarity between atropine and acetylcholine, which allows atropine to bind to the receptor and prevent acetylcholine from activating it.

**Why Each Wrong Option is Incorrect**
**Option A:** Nicotinic receptors are activated by acetylcholine, but they are blocked by curare, a nicotinic receptor antagonist, not atropine.
**Option C:** Alpha 1 and 2 receptors are a subtype of adrenergic receptors, which are activated by catecholamines such as adrenaline and noradrenaline, not acetylcholine.
**Option D:** Beta 1 and 2 receptors are also a subtype of adrenergic receptors, which are activated by catecholamines, not acetylcholine.

**Clinical Pearl / High-Yield Fact**
Atropine is often used in clinical settings to block the effects of excess acetylcholine, such as in cases of organophosphate poisoning or in the treatment of bradycardia. It is also used to dry secretions in patients with respiratory or gastrointestinal disorders.

✓ Correct Answer: B. Muscarinic